N Verses Capital, LLC Amneal Pharmaceuticals, Inc. Transaction History
N Verses Capital, LLC
- $167 Billion
- Q2 2024
A detailed history of N Verses Capital, LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, N Verses Capital, LLC holds 9,800 shares of AMRX stock, worth $84,475. This represents 0.04% of its overall portfolio holdings.
Number of Shares
9,800Holding current value
$84,475% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding AMRX
# of Institutions
186Shares Held
137MCall Options Held
234KPut Options Held
45.9K-
Ubs Group Ag21.8MShares$188 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$121 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$106 Million1.95% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$97.3 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$92.4 Million2.02% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.31B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...